TYVYT
Live / Registered — Registered (as of 17 Dec 2019)
What this means for you
Registered since 17 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79253564
- Registration number
- 5934673
- Mark type
- Stylized text
- Filed
- 03 Jan 2019
- Published for opposition
- 01 Oct 2019
- Registered
- 17 Dec 2019
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; pharmaceutical preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; vaccines; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; biological preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; antibiotics; diagnostic preparations for medical purposes; dietetic foods adapted for medical use
Owner
- Eli Lilly and Company, US
- Innovent Biologics (Suzhou) Co., Ltd., Suzhou City 21, CN
- Innovent Biologics (Suzhou) Co., Ltd., Suzhou City 21, CN
- Innovent Biologics (Suzhou) Co., Ltd., Suzhou City 21, CN
Prosecution history
- 17 Dec 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 30 Jul 2021 — CHANGE OF OWNER RECEIVED FROM IB
- 17 Apr 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 28 Mar 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Mar 2020 — FINAL DISPOSITION PROCESSED
- 17 Mar 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 17 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 05 Oct 2019 — NOTIFICATION PROCESSED BY IB
- 01 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2019 — PUBLISHED FOR OPPOSITION
- 18 Sept 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 18 Sept 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 11 Sept 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Aug 2019 — ASSIGNED TO LIE
- 23 Aug 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER